| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 4/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 3/6 |
Guangdong Zhongsheng Pharmaceutical Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥14.26 |
| 52 Week High | CN¥22.80 |
| 52 Week Low | CN¥10.22 |
| Beta | 0.64 |
| 1 Month Change | -13.05% |
| 3 Month Change | 2.89% |
| 1 Year Change | -35.09% |
| 3 Year Change | 59.15% |
| 5 Year Change | 43.75% |
| Change since IPO | 42.30% |
Recent News & Updates
Does Guangdong Zhongsheng Pharmaceutical (SZSE:002317) Have A Healthy Balance Sheet?
Mar 18
Guangdong Zhongsheng Pharmaceutical Co., Ltd.'s (SZSE:002317) Shares Climb 29% But Its Business Is Yet to Catch Up
Feb 29Shareholder Returns
| 2317 | CN Pharmaceuticals | CN Market | |
|---|---|---|---|
| 7D | -0.8% | 3.0% | 1.6% |
| 1Y | -35.1% | -12.9% | -15.1% |
Return vs Industry: 002317 underperformed the CN Pharmaceuticals industry which returned -12.9% over the past year.
Return vs Market: 002317 underperformed the CN Market which returned -15.1% over the past year.
Price Volatility
| 2317 volatility | |
|---|---|
| 2317 Average Weekly Movement | 8.1% |
| Pharmaceuticals Industry Average Movement | 7.7% |
| Market Average Movement | 8.8% |
| 10% most volatile stocks in CN Market | 12.6% |
| 10% least volatile stocks in CN Market | 5.3% |
Stable Share Price: 002317's share price has been volatile over the past 3 months.
Volatility Over Time: 002317's weekly volatility (8%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | 1,732 | Yong Hong Chen | www.zspcl.com |
Guangdong Zhongsheng Pharmaceutical Co., Ltd. engages in research, development, production, and sale of pharmaceuticals in China. The company offers Chinese and chemical medicines, raw materials, and intermediates. It is also involved in the research and development of products in the fields of ophthalmology, cardiovascular, cerebrovascular, respiratory, digestive, diabetes, tumor, and senile degenerative diseases.
Guangdong Zhongsheng Pharmaceutical Co., Ltd. Fundamentals Summary
| 2317 fundamental statistics | |
|---|---|
| Market cap | CN¥12.09b |
| Earnings (TTM) | CN¥175.19m |
| Revenue (TTM) | CN¥2.50b |
69.0x
P/E Ratio4.8x
P/S RatioIs 2317 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 2317 income statement (TTM) | |
|---|---|
| Revenue | CN¥2.50b |
| Cost of Revenue | CN¥1.07b |
| Gross Profit | CN¥1.43b |
| Other Expenses | CN¥1.26b |
| Earnings | CN¥175.19m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.21 |
| Gross Margin | 57.18% |
| Net Profit Margin | 6.99% |
| Debt/Equity Ratio | 9.4% |
How did 2317 perform over the long term?
See historical performance and comparison